JMP Securities downgraded Marinus Pharmaceuticals (MRNS) to Market Perform from Outperform.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNS:
- Marinus Pharmaceuticals downgraded to Hold from Buy at Truist
- Marinus notes TrustTSC trial misses primary endpoint, to evaluate alternatives
- Marinus Pharmaceuticals presents clinical data from pivotal phase 3 RAISE trial
- Biotech Alert: Searches spiking for these stocks today
- Microsoft downgraded, Pinterest initiated: Wall Street’s top analyst calls